Related Experiment Video

Updated: Jul 7, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
05:06

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review

Published on: March 27, 2026

[Clinical features of sideropenic anemias in infants and small children]

Edo Hasanbegović1

  • 1Pedijatrijska klinika, Klinicki centar Univerziteta u Sarajevu.

Medicinski Arhiv
|February 1, 2008
PubMed

Insights

Iron-deficiency anemia (IDA) is common in children. Key clinical signs like paleness, dry skin, and brittle hair indicate IDA severity, guiding treatment for this frequent childhood anemia.

Area of Science:

  • Pediatrics
  • Hematology
  • Nutritional Science

Context:

  • Iron-deficiency anemia (IDA) is the most prevalent anemia globally in childhood.
  • Early identification of IDA is crucial for appropriate management and preventing long-term complications.

Purpose:

  • To delineate the primary clinical manifestations of iron-deficiency anemia (IDA) in infants and young children.
  • To correlate specific clinical signs with varying degrees of anemia severity based on hemoglobin levels.

Summary:

  • A retrospective study analyzed anemic children (Hb < 110 g/l) and a control group (Hb > 110 g/l) aged 6-24 months.
  • Universal findings included paleness; statistically significant differences were observed in dry, scaly skin (p=0.006) and brittle, light hair (p=0.003) in severe IDA (Hb < 95 g/l).
  • No significant growth retardation was noted between groups, suggesting localized clinical signs are key indicators.

Impact:

  • Clinical features of IDA, alongside hemoglobin levels, are pivotal in determining anemia severity.
  • This information guides therapeutic strategies and treatment directions for iron-deficiency anemia in pediatric populations.
  • Highlights the importance of recognizing specific physical signs for early diagnosis and intervention in pediatric IDA.
Abstract

More Related Videos

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...